MedElevator
Войти в исследования Journal of public health dentistry · 2026
Trend in Opioid Analgesic Prescriptions and High-Risk Prescribing in the State of Illinois: An Eight-Year Descriptive Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sangalli L, Bolch C, Rojas-Ramirez M V
Аннотация
OBJECTIVE: Given the significant opioid epidemic in the United States, we investigated opioid-analgesic prescription trends and high-risk prescriptions in Illinois between 2015-2022.
METHODS: Data from the Illinois Prescription Monitoring Program were analyzed for opioid prescription rates and high-risk prescriptions (i.e., multiple-prescribing providers, concurrent benzodiazepine, ≥ 90MME dose). Demographics (sex, age, and rural/urban classification using the Illinois Primary Health Care Association-2020) of high-risk prescriptions between 2018-2020 were analyzed using chi-square tests.
RESULTS: N = 45,522,885 opioid prescriptions were dispensed in Illinois between 2015-2022, declining by 47.1% (from 140.5 rate in 2015 to 74.4 in 2022). High-risk prescriptions comprise 12.6% of all prescriptions and decreased by 16.6% (from 16.9% in 2015 to 14.1% in 2022). Between 2018-2020, males received more high-risk prescriptions than females, although both males and females showed a reduction in ≥ 90MME prescriptions (19.5% vs. 15.9%, p < 0.0001) and multiple-provider prescriptions (36.1% vs. 27.3%, p < 0.0001). Individuals aged 56-70 received the highest high-risk prescriptions, while reductions in ≥ 90MME prescriptions occurred across all age groups. High-risk prescriptions were disproportionally dispensed in rural areas (67.8%), where reductions were greater in ≥ 90MME prescriptions (16.7% rural vs. 6.4% urban) and multiple-provider prescriptions (9.0% rural vs. 7.9% urban).
CONCLUSIONS: Despite declines in opioid-analgesic prescriptions in Illinois from 2015 to 2022, high-risk prescribing persists, particularly in rural areas and among specific demographic groups. Targeted, region-specific interventions and continued regulatory oversights are necessary to address geographic and population-level disparities in high-risk opioid prescribing.
METHODS: Data from the Illinois Prescription Monitoring Program were analyzed for opioid prescription rates and high-risk prescriptions (i.e., multiple-prescribing providers, concurrent benzodiazepine, ≥ 90MME dose). Demographics (sex, age, and rural/urban classification using the Illinois Primary Health Care Association-2020) of high-risk prescriptions between 2018-2020 were analyzed using chi-square tests.
RESULTS: N = 45,522,885 opioid prescriptions were dispensed in Illinois between 2015-2022, declining by 47.1% (from 140.5 rate in 2015 to 74.4 in 2022). High-risk prescriptions comprise 12.6% of all prescriptions and decreased by 16.6% (from 16.9% in 2015 to 14.1% in 2022). Between 2018-2020, males received more high-risk prescriptions than females, although both males and females showed a reduction in ≥ 90MME prescriptions (19.5% vs. 15.9%, p < 0.0001) and multiple-provider prescriptions (36.1% vs. 27.3%, p < 0.0001). Individuals aged 56-70 received the highest high-risk prescriptions, while reductions in ≥ 90MME prescriptions occurred across all age groups. High-risk prescriptions were disproportionally dispensed in rural areas (67.8%), where reductions were greater in ≥ 90MME prescriptions (16.7% rural vs. 6.4% urban) and multiple-provider prescriptions (9.0% rural vs. 7.9% urban).
CONCLUSIONS: Despite declines in opioid-analgesic prescriptions in Illinois from 2015 to 2022, high-risk prescribing persists, particularly in rural areas and among specific demographic groups. Targeted, region-specific interventions and continued regulatory oversights are necessary to address geographic and population-level disparities in high-risk opioid prescribing.